HFQRX
Price
$8.20
Change
+$0.19 (+2.37%)
Updated
Jun 11 closing price
Net Assets
7.63B
LIRTX
Price
$11.71
Change
+$0.09 (+0.77%)
Updated
Jun 12 closing price
Net Assets
532.58M
Interact to see
Advertisement

HFQRX vs LIRTX

Header iconHFQRX vs LIRTX Comparison
Open Charts HFQRX vs LIRTXBanner chart's image
HFQRX vs LIRTX Comparison Chart in %
View a ticker or compare two or three
VS
HFQRX vs. LIRTX commentary
Jun 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HFQRX is a StrongBuy and LIRTX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
HFQRX has more cash in the bank: 7.63B vs. LIRTX (533M). HFQRX pays higher dividends than LIRTX: HFQRX (6.34) vs LIRTX (2.72). HFQRX was incepted earlier than LIRTX: HFQRX (11 years) vs LIRTX (11 years). LIRTX (0.73) is less costly to investors than HFQRX (0.69). HFQRX is a more actively managed with annual turnover of: 175.00 vs. LIRTX (66.00). LIRTX has a lower initial minimum investment than HFQRX: LIRTX (0) vs HFQRX (1000000). LIRTX (26.15) and HFQRX (25.65) have marching annual gain over last year. HFQRX return over 5 years is better than : 67.18 vs. LIRTX (56.71).
HFQRXLIRTXHFQRX / LIRTX
Total Expense Ratio0.690.7395%
Annual Report Gross Expense Ratio0.690.7395%
Fund Existence11 years11 years-
Gain YTD13.55711.224121%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets7.63B533M1,432%
Annual Yield % from dividends6.342.72233%
Returns for 1 year25.6526.1598%
Returns for 3 years67.6076.1689%
Returns for 5 years67.1856.71118%
Returns for 10 years133.67126.54106%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CVLT127.760.93
+0.73%
Commvault Systems
MACI10.79N/A
N/A
Melar Acquisition Corp. I
AVNS24.96-0.02
-0.08%
Avanos Medical
MPWR1577.32-12.23
-0.77%
Monolithic Power Systems
AKTX13.40-1.42
-9.58%
Akari Therapeutics Plc